Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities - The role of cytogenetics in classification and prognostication

被引:59
作者
Bassett, MD
Schuetze, SM
Disteche, C
Norwood, TH
Swisshelm, K
Chen, XQ
Bruckner, J
Conrad, EU
Rubin, BP
机构
[1] Univ Washington, Ctr Med, Dept Pathol Anat, Seattle, WA 98195 USA
[2] Univ Washington, Ctr Med, Dept Oncol, Seattle, WA 98195 USA
[3] Univ Washington, Ctr Med, Dept Cytogenet, Seattle, WA 98195 USA
[4] Univ Washington, Ctr Med, Dept Orthoped Surg, Seattle, WA 98195 USA
关键词
atypical lipomatous tumor; well differentiated liposarcoma; intramuscular lipoma; cytogenetics;
D O I
10.1002/cncr.20779
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. intramuscular lipomas and atypical lipomatous tumors (ALT) are common deep-seated lipomatous tumors of the chest wall and extremities. Distinguishing between these two entities can be difficult based on histologic analysis alone. However, the cytogenetic profiles of ALT and intramuscular lipomas are distinct. Correct classification is important, because aggressive local disease recurrence Occurs more frequently in patients with ALT than in patients with intramuscular lipoma. The authors examined their single institutional experience and correlated their classification with clinical features and outcome. METHODS. in the Current study, 106 patients with deep-seated, well differentiated adipose tumors of the chest wall and extremities were classified as having ALT or intramuscular lipoma using a combined approach of histology and cytogenetics, if available. The classification was correlated with clinicopathologic features and follow-up data. RESULTS. Fifty-five patients were classified as having intramuscular lipoma and 51 were classified as having ALT. Classification did not correlate with age and gender (P = 0.28 and P = 0.96, respectively). Intramuscular lipomas were smaller than ALTs (P < 0.0001), but there was significant overlap between the 2 groups. ALT occurred preferentially in the lower extremity (P < 0.0009). Four. percent of patients with intramuscular lipomas and 27% of patients with ALTs developed local disease recurrence (P = 0.0006). Disease recurrence did not correlate with patient age at diagnosis, patient gender, turner size, and tumor location (P = 0.45, P = 0.26, P = 0.49, and P = 0.28, respectively). Within the subset of patients with ALTs, disease recurrence did not correlate with patient age at diagnosis, patient gender, or tumor location (P = 0.38, P = 0.54, and P = 0.86, respectively). CONCLUSIONS. Classification of deep-seated, well differentiated lipomatous tumors of the extremities and chest wall using a combined approach of histology and cytogenetics correlated well with biologic behavior/disease recurrence. This combined approach is advocated to better stratify patients for treatment purposes and follow-up. (C) 2004 American Cancer Society.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 29 条
[1]   Genomic characterization of human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas [J].
Ashar, HR ;
Cherath, L ;
Przybysz, KM ;
Chada, K .
GENOMICS, 1996, 31 (02) :207-214
[2]   ATYPICAL AND MALIGNANT NEOPLASMS SHOWING LIPOMATOUS DIFFERENTIATION - A STUDY OF 111 CASES [J].
AZUMI, N ;
CURTIS, J ;
KEMPSON, RL ;
HENDRICKSON, MR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1987, 11 (03) :161-183
[3]   CYTOGENETIC AND FLUORESCENCE IN-SITU HYBRIDIZATION INVESTIGATION OF RING CHROMOSOMES CHARACTERIZING A SPECIFIC PATHOLOGICAL SUBGROUP OF ADIPOSE-TISSUE TUMORS [J].
DALCIN, P ;
KOOLS, P ;
SCIOT, R ;
DEWEVER, I ;
VANDAMME, B ;
VANDEVEN, W ;
VANDENBERGHE, H .
CANCER GENETICS AND CYTOGENETICS, 1993, 68 (02) :85-90
[4]  
DIONNE GP, 1974, CANCER-AM CANCER SOC, V33, P732, DOI 10.1002/1097-0142(197403)33:3<732::AID-CNCR2820330319>3.0.CO
[5]  
2-3
[6]  
Enzinger FM, 1977, MANAGEMENT PRIMARY B, P11
[7]  
EVANS HL, 1979, CANCER, V43, P574, DOI 10.1002/1097-0142(197902)43:2<574::AID-CNCR2820430226>3.0.CO
[8]  
2-7
[9]  
Evans HL, 1988, SURG PATHOL, V1, P41
[10]  
Fletcher CD, 2000, DIAGNOSTIC HISTOPATH, Vsecond, P1473